Clinical Trial Categories
  • Age & Physical Activity (1)
  • Alzheimer's Disease (7)
  • Arthritis (3)
  • Asthma (1)
  • Cancer - Bladder (1)
  • Cancer - Brain & CNS (16)
  • Cancer - Breast (8)
  • Cancer - Colon/Colorectal (2)
  • Cancer - Digestive System (2)
  • Cancer - Female Reproductive (8)
  • Cancer - Gastric (1)
  • Cancer - Kidney (2)
  • Cancer - Leukemia (6)
  • Cancer - Liver (1)
  • Cancer - Lung (3)
  • Cancer - Lymphoma (27)
  • Cancer - Melanoma (15)
  • Cancer - Mesothelioma (2)
  • Cancer - Myeloma (10)
  • Cancer - Other (5)
  • Cancer - Ovarian (2)
  • Cancer - Pancreas (2)
  • Cancer - Peritoneal (5)
  • Cancer - Prostate (12)
  • Cancer - Sarcoma (1)
  • Cancer - Stomach (1)
  • Cancer - Testicular (1)
  • Cancer - Tissue (6)
  • Crohn's Disease (3)
  • Dermatitis (2)
  • Dermatomyositis (1)
  • Healthy (6)
  • Hepatitis C (2)
  • HIV (4)
  • HPV (1)
  • Hypercholesterolemia (1)
  • Immune Disease - Autoimmune (9)
  • Immune Disease - Primary (2)
  • Immune Disease - Secondary (6)
  • Infectious Disease (2)
  • Inflammatory Disease (3)
  • Kidney Transplant (1)
  • Liver Disease (2)
  • Lupus Erythematosus (3)
  • Multiple Sclerosis (3)
  • Neurodegenerative (1)
  • OX40 (1)
  • Parkinson's Disease (1)
  • Pediatric (3)
  • Transplant (2)

KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Friday
Mar092012

NCT01552681

Baminercept in Sjögren's Syndrome

Conditions: Sjögren's Syndrome
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase: II

Date: DateMarch 9, 2012
Categories CategoryImmune Disease - Autoimmune
Tags ,
Thursday
Jan192012

NCT01516307

Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

A Double-blind, Randomized Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Subjects With Metastatic Breast Cancer

Conditions: Metastatic Breast Cancer
Sponsors: OBI Pharma, Inc.
Phase II

Date: DateJanuary 19, 2012
Categories CategoryCancer - Breast
Tags , ,
Monday
Jan092012

NCT01509391

Keyhole Limpet Hemocyanin in Chronic Hepatitis C (IM1)

Conditions: Chronic Hepatitis C, Liver Cirrhosis
Sponsors: Medical University of Graz
Phase n/a

Date: DateJanuary 9, 2012
Categories CategoryHepatitis C, CategoryInfectious Disease, CategoryLiver Disease
Tags ,
Monday
Jan092012

 Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - IM1

Conditions: Chronic Hepatitis C, Liver Cirrhosis
Sponsors: Medical University of Graz
Phase n/a

Date: DateJanuary 9, 2012
Categories CategoryHepatitis C, CategoryInfectious Disease, CategoryLiver Disease
Tags ,
Wednesday
Dec212011

NCT01498328

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma (ReACT)

Conditions: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
Sponsors: Celldex Therapeutics
Phase II

Date: DateDecember 21, 2011
Categories CategoryCancer - Brain & CNS
Tags , , , , ,
Thursday
Dec012011

NCT01489956

A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)

Conditions: Autoimmune Disorders
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) 
Phase 0 completed

Date: DateDecember 1, 2011
Categories CategoryHealthy, CategoryImmune Disease - Autoimmune
Tags , , , , ,
Monday
Nov212011

NCT01480479

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)

Conditions: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
Sponsors: Celldex Therapeutics
Phase III

Date: DateNovember 21, 2011
Categories CategoryCancer - Brain & CNS
Tags , , , ,
Tuesday
Oct182011

NCT01456104

Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma

Conditions: Melanoma
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase 1

Date: DateOctober 18, 2011 | Reference1 Reference
Categories CategoryCancer - Melanoma
Tags ,
Tuesday
Aug302011

NCT01426828

Id-KLH Vaccine + T Cells

Conditions: Multiple Myeloma
Sponsors: Abramson Cancer Center of the University of Pennsylvania
Phase 2

Date: DateAugust 30, 2011
Categories CategoryCancer - Myeloma
Tags , ,
Thursday
May052011

NCT01349647

Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid

Conditions: Lung Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Phase: n/a 

Date: DateMay 5, 2011
Categories CategoryCancer - Lung
Tags , , ,
Page 1 ... 2 3 4 5 6 ... 16 Next 10 Entries »